Insider · CIK 0002144943
Madan Jagasia
Files at OBX (Obsidian Therapeutics, Inc.). First filing -, latest -.
In brief
Madan Jagasia files SEC Form 4 as CEO and director at OBX (Obsidian Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Madan Jagasia has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | OBX Obsidian Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +37,653 | $0.00 | $0 | 37,653 | Aug 5, 2026 |
Questions about Madan Jagasia
Answered from the filings on this page, as of the latest one.
Is Madan Jagasia buying or selling?
Madan Jagasia has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Madan Jagasia's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Madan Jagasia has 0.
Where does Madan Jagasia file Form 4?
Madan Jagasia has filed Form 4 at OBX (Obsidian Therapeutics, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.